Seattle Position Open for Leukemia & Lymphoma Society

Campaign Coordinator – Washington / Alaska Chapter

The Washington/Alaska Chapter of The Leukemia & Lymphoma Society is looking for a highly organized and dynamic individual to implement and execute our 2010 Leukemia Cup Regatta / AquaQuest Power Boat Campaign, and other select fundraising and volunteer projects at the chapter.

Assigned duties and Responsibilities include:

•Formulate, direct and implement, all aspects of the Leukemia Cup Regatta and AquaQuest Programs.

•Identify and build relationships with the sailing and power boating communities as an integral part of prospect development and engagement of the Society's revenue generating activities.

• Help recruit and conduct event related kick-offs and presentations at local yacht clubs as applicable.

•Develop, direct and manage volunteer leadership, committees, and corporate sponsorship.

•Ensure growth through implementation of key fundraising elements to maximize expansion of core markets.

•Manage budget and control expenses to effectively meet and exceed income goals.

•Develop recruitment & retention plans with timelines to ensure implementation.

•Support and maintain a working knowledge of the mission of LLS and its programs.

•Perform other related duties as assigned.

The highly organized individual we seek will have the following:

•Bachelor's Degree
•2+ years fundraising, sales experience
•Outstanding relationship management skills.
•Able to work independently and collaboratively with a variety of personalities and leadership styles
•Professional demeanor
•Strong word processing and database management skills
•Excellent written and verbal communication skills
•Ability to manage multiple priorities effectively

For consideration, please forward cover letter and resume to: Kristen Howard, Sr. Campaign Director at Kristen.howard@lls.org. Deadline for consideration is January 14, 2010.

Blog Category: 

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap